Drawing for TAKE CARE OF MORE THAN MOOD

USPTO serial 86431484

TAKE CARE OF MORE THAN MOOD

Reviewed by CopyMark Law Group

Reg. 4879581Status 710
Filing date
Status date
Registration date
Jan 5, 2016
Examiner
VAGHANI, MAYUR C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with TAKE CARE OF MORE THAN MOOD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia A. Smith

CLAUDIA A. SMITH WHITE & CASE LLPPatent and Trademark Department1155 AVENUE OF THE AMERICASNEW YORK, NY 10036-2711

Goods and services

ClassDescriptionStatusFirst use
005Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; medical diagnostic preparations for medical purposes, reagents for medical use, diagnostic agents preparations and substances for medical purposesSECTION 8 - CANCELLED—
041Education services, namely, providing continuing medical education courses; providing of training, namely, medical training and teaching; arranging and conducting educational seminars, conferences, symposiums, workshops, training and courses in the field of medicine; educational classes, courses, seminars and workshops and training services in the field of research and development for the treatment and prevention of brain and central nervous system diseases and disorders, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational services, namely, seminars, conferences, symposiums, workshops, training and courses and training services in the field of medical research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease provided electronically, on-line, via the Internet and global communications networks; education services, namely, arranging and conducting of expert forums, in the form of seminars, conferences, symposia, workshops and courses in the field of medicine; educational services, namely, providing medical training online; providing non-downloadable, on-line publications, namely, books, reports, brochures, booklets, leaflets, including patient information leaflets, magazines, journals, teaching and educational material in the nature of articles, journals in the field of medical research and development, science, clinical tests and trials, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of diseaseSECTION 8 - CANCELLED—
042Scientific and technological services, namely, scientific research in the field of medicine; industrial analysis in the nature of research services in the field of pharmaceuticals; providing online non-downloadable software in the field of research and development for use in database management in the field of the treatment and prevention of brain and central nervous system diseases and disorder and an online searchable database in the field of scientific research and development of clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention all for the purpose of scientific research; providing a secured-access website that gives registered medical experts the ability to upload, view, download, and share documents and images for the purposes of research and development in the field of clinical tests and trials, science, patient diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease; pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, diseases and prevention of disease; scientific and technological services, namely, scientific research in the field of the treatment and prevention of brain and central nervous system related disorders, diseases and pharmaceuticals; medical research, conducting clinical medical trials and testing in the field of pharmaceuticals for others; medical services, namely, medical research; medical diagnostic research and tests, namely, clinical trials for others; providing medical research information in the field of pharmaceutical research and development, clinical tests and trialsSECTION 8 - CANCELLED—
044Medical services in the field of psychiatry and psychology, namely, medical advice related to medical and pharmaceutical preparations and substances; medical clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; medical treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing information relating to diagnostic and therapeutic properties of pharmaceuticals in the field of disorders, diseases, treatment and prevention; providing medical information services; providing on-line medical data and analyses designed to provide patients and clients customized information, including medical dose, diagnosis, therapeutic issues and medical management; providing an online database in the field of medical diagnosis and treatment of brain and central nervous system diseases and disordersSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 15, 2022C8..CANCELLED SEC. 8 (6-YR)—
Jan 5, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 5, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 20, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 20, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 15, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 9, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 9, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Sep 9, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 9, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 9, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 22, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 22, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 12, 2015ALIEASSIGNED TO LIE—
Jul 29, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 10, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2015DOCKASSIGNED TO EXAMINER—
Oct 30, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 25, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance